Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Virchows Archiv
Published in: Virchows Archiv 2/2006

01-08-2006 | Letter to the Editor

Immunohistochemical evaluation of a novel clone of monoclonal anti-MYCN antibody B8.4B in neuroblastic tumours: a correlation with MYCN gene status

Authors: Rosa Noguera, Marta Piqueras, Manish Subramaniam, Julia Cruz, Adela Cañete, Antonio Llombart Bosch, Samuel Navarro

Published in: Virchows Archiv | Issue 2/2006

Login to get access

Excerpt

To the Editor, …
Literature
1.
Ambros PF, Ambros IM (2001) Pathology and biology guidelines for resectable and unresectable neuroblastic tumos and bone marrow examination guidelines. Med Pediatr Oncol 37:492–504PubMedCrossRef
2.
Chan HSL, Gallie BL, DeBoer G, Haddad G, Ikegaki N, Dimitrouloakos J, Yeger H, Ling V (1997) MYCN protein expression as a predictor of neuroblastoma prognosis. Clin Cancer Res 3:1699–1706PubMed
3.
Cohn SL, London WB, Huang D, Katzenstein HM, Salwen HR, Reinhart T, Madafiglia J, Marshall GM, Norris MD, Haber M (2000) MYCN expression is not prognostic of adverse outcome in advanced-stage neuroblastoma with non-amplified MYCN. J Clin Oncol 18:3604–3613PubMed
4.
Hiyama E, Hiyama K, Yokoyama T, Ishii T (1991) Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients. J Pediatr Surg 26:838–843PubMedCrossRef
5.
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111–1116PubMedCrossRef
Metadata
Title
Immunohistochemical evaluation of a novel clone of monoclonal anti-MYCN antibody B8.4B in neuroblastic tumours: a correlation with MYCN gene status
Authors
Rosa Noguera
Marta Piqueras
Manish Subramaniam
Julia Cruz
Adela Cañete
Antonio Llombart Bosch
Samuel Navarro
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Virchows Archiv / Issue 2/2006
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-006-0227-0

Other articles of this Issue 2/2006

Virchows Archiv 2/2006 Go to the issue

Original Article

Extranodal follicular dendritic cell sarcoma: clinical, pathologic, and histogenetic characteristics of an underrecognized disease entity

Original Article

CD10 expression by fusiform stromal cells in nasopharyngeal carcinoma correlates with tumor progression

Letter to the editor

Accessible calculation of multirater kappa statistics for pathologists

Original Article

Survivin expression in pre-invasive lesions and non-small cell lung carcinoma

Original Article

C4d deposits mark sites of meniscal tissue disintegration

Original Article

Coexistence of Epstein–Barr virus-associated gastric carcinoma with malignant lymphoma: report of two cases